DAXIENCE Trademark

Trademark Overview


On Thursday, August 15, 2019, a trademark application was filed for DAXIENCE with the United States Patent and Trademark Office. The USPTO has given the DAXIENCE trademark a serial number of 88579928. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 27, 2023. This trademark is owned by Revance Therapeutics, Inc. The DAXIENCE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, cerebral palsy, muscle spasms, muscle tremors and pain; pharmaceutical preparations, namely, peptide substrates for use in the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, cerebral palsy, muscle spasms, muscle tremors and pain; body creams, lotions and gels for medical purposes; eye creams, lotions and gels for medical purposes
daxience

General Information


Serial Number88579928
Word MarkDAXIENCE
Filing DateThursday, August 15, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 27, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 24, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, cerebral palsy, muscle spasms, muscle tremors and pain; pharmaceutical preparations, namely, peptide substrates for use in the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, cerebral palsy, muscle spasms, muscle tremors and pain; body creams, lotions and gels for medical purposes; eye creams, lotions and gels for medical purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 30, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRevance Therapeutics, Inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNewark, CA 94560

Party NameRevance Therapeutics, Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNewark, CA 94560

Trademark Events


Event DateEvent Description
Monday, March 27, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 27, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 2, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 1, 2022SOU EXTENSION 5 GRANTED
Thursday, July 28, 2022SOU EXTENSION 5 FILED
Thursday, July 28, 2022TEAS EXTENSION RECEIVED
Wednesday, February 2, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 1, 2022SOU EXTENSION 4 GRANTED
Friday, January 28, 2022SOU EXTENSION 4 FILED
Friday, January 28, 2022TEAS EXTENSION RECEIVED
Tuesday, August 10, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 9, 2021SOU EXTENSION 3 GRANTED
Tuesday, August 3, 2021SOU EXTENSION 3 FILED
Monday, August 9, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 3, 2021TEAS EXTENSION RECEIVED
Thursday, January 7, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 5, 2021SOU EXTENSION 2 GRANTED
Tuesday, January 5, 2021SOU EXTENSION 2 FILED
Tuesday, January 5, 2021TEAS EXTENSION RECEIVED
Saturday, April 18, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 16, 2020SOU EXTENSION 1 GRANTED
Thursday, April 16, 2020SOU EXTENSION 1 FILED
Thursday, April 16, 2020TEAS EXTENSION RECEIVED
Tuesday, February 18, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 24, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 24, 2019PUBLISHED FOR OPPOSITION
Wednesday, December 4, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, November 15, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 15, 2019ASSIGNED TO EXAMINER
Friday, August 30, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 19, 2019NEW APPLICATION ENTERED